Cardiac Valve Market Research Report-Forecast till 2027

Cardiac Valve Market Research Report: Information by Treatment (Cardiac Valve Repair and Cardiac Valve Replacement), Type (Mechanical Valves, Tissue/Bioprosthetic Valves, Transcatheter Heart Valves/ Percutaneous Heart Valves and others), Position (Mitral Valve Aortic Valve and other Position), End-User (Hospital & Clinics, Specialty Centers, Cardiac Research Institute and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/0117-HCR | February 2021 | Region: Global | 110 pages

Market Scenario


Cardiac Valve Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 6200 Million in 2018 and is projected to register a valuation of USD 13355.2 Million by 2025, with a CAGR of 11.6% over the forecast period.


Cardiac diseases broadly cover a range of conditions affecting the heart. The implantation of cardiac valves has increased substantially over the last decade due to the increasing patient population suffering from cardiovascular diseases. Cardiac valves are responsible for uninterrupted blood flow by maintaining blood pressure. The technological advancements in cardiac valve devices, increasing prevalence of congenital heart defects (CHD), rising geriatric population are likely to provide favorable conditions for the growth of the market during the forecast period.


Various other factors, such as the changing lifestyle and increasing geriatric population, are also expected to propel the growth of the market.


However, the high cost of cardiac valves and risk of infection due to cardiac implants can hamper market growth over the forecast period.


Segmentation


The global cardiac valve market is segmented based on treatment, type, position, end user, and region.


The global market for cardiac valve, by treatment, is divided into cardiac valve repair and cardiac valve replacement.


Based on type, the global market is segmented into mechanical valves, tissue/bioprosthetic valves, transcatheter heart valves/ percutaneous heart valves, and others.


Based on position, the global market is segmented into mitral valve, aortic valve, and other position.


Based on end user, the global market is segmented into hospitals & clinics, specialty centers, cardiac research institute, and others.


In the current scope of the study, the segments mentioned above are covered under four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East & Africa.


The cardiac valve Industry in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European cardiac valve market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The cardiac valve market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Cardiac Valve Global Market Share (%), by Region, 2018


Sources: MRFR Analysis


The Americas dominated the market for cardiac valves owing to the growing prevalence of cardiac diseases, high adoption rates of cardiac devices, and the presence of a well-established healthcare sector. According to the American Heart Association, an estimated 1.5 million cases of myocardial infarction occur in the US every year. Additionally, according to the Centers for Disease Control and Prevention (CDC), about 610,000 people die of heart disease in the US every year. Moreover, the growing geriatric population in the region is expected to fuel market growth.


In 2018, it was estimated that Europe stood second in the global cardiac valve market. The increasing funding from the government for the healthcare sector and growing initiatives for heart patients by insurance companies in the region. Moreover, technological advancements in the region and increasing demand for efficient treatment solutions for cardiovascular disorders is expected to drive the growth of the market. Germany commanded the largest share in the European market for cardiac valves.  


Asia-Pacific (APAC) is expected to witness the fastest growth in the cardiac valve market during the forecast period due to the increasing geriatric population, changing lifestyle, and increasing medical tourism in the region. Countries in Asia-Pacific are adopting advanced treatment options, which in turn fuels the market growth in this region. Moreover, the presence of countries such as China, India, and Japan is expected to drive the regional market growth.


On the other hand, the Middle East & Africa is expected to hold the least share of the cardiac valve market due to the low economic development, especially in Africa.


Key Players


Some of the key players operating in the global cardiac valve market are Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, LivaNova PLC, Abbott, CryoLife, Inc, On-X Life Technologies, Inc., Colibri Heart Valve, JenaValve Technology, Inc., and TTK HealthCare.


Market Segmentation


Cardiac Valve Market, by Treatment



  • Cardiac Valve Repair

  • Cardiac Valve Replacement


Cardiac Valve Market, by Type



  • Mechanical Valves

  • Tissue/Bioprosthetic Valves

  • Transcatheter Heart Valves/ Percutaneous Heart Valves

  • Others


Cardiac Valve Market, by Position



  • Mitral Valve

  • Aortic Valve

  • Other Position


Cardiac Valve Market, by End User



  • Hospital & Clinics

  • Specialty Centers

  • Cardiac Research Institute

  • Other


Intended Audience



  • Cardiac valve manufacturing companies

  • Healthcare organizations

  • Healthcare providers

  • Government organizations

  • Medical device manufacturers

  • Research and development (R&D) companies



Report Scope:
Report Attribute/Metric Details
  Market Size   2025: USD 13355.2 Million
  CAGR   11.6% (2019-2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Treatment, Type, Position and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, LivaNova PLC, Abbott, CryoLife, Inc, On-X Life Technologies, Inc., Colibri Heart Valve, JenaValve Technology, Inc., and TTK HealthCare
  Key Market Opportunities   Increasing prevalence of congenital heart defects (CHD), rising geriatric population are likely to provide favorable conditions
  Key Market Drivers

  • Increasing demand for efficient treatment solutions for cardiovascular disorders.
  • Huge demand for new treatment methods for vulvar heart diseases


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The valuation of Cardiac Valve Market was USD 6200 million.

    The market valuation of Cardiac Valve Market would be USD 133.55.2 million.

    The CAGR of Cardiac Valve Market would be 11.6% during the forecast period.

    High cost and risk of infection can slacken the growth pace of the Cardiac Valve Market.

    The segments are cardiac valve repair and Cardiac Valve replacement.

    Table of Contents

    1. REPORT PROLOGUE

    2. MARKET INTRODUCTION

    2.1. Definition

    2.2. Scope of the Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations

    3. RESEARCH METHODOLOGY

    3.1. Overview

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Size Estimation

    4. MARKET DYNAMICS

    4.1. Overview

    4.2. Drivers

    4.3. Restraints

    4.4. Opportunities

    5. MARKET FACTOR ANALYSIS

    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power of Suppliers

    5.1.2. Bargaining Power of Buyers

    5.1.3. Threat of New Entrants

    5.1.4. Threat of Substitutes

    5.1.5. Intensity of Rivalry

    5.2. Value Chain Analysis

    6. GLOBAL CARDIAC VALVE MARKET, BY TREATMENT

    6.1. Overview

    6.2. Cardiac Valve Repair

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3. Cardiac Valve Replacement

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7. GLOBAL CARDIAC VALVE MARKET, BY TYPE

    7.1. Overview

    7.2. Mechanical Valves

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3. Tissue/Bioprosthetic Valves

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4. Transcatheter Heart Valves/Percutaneous Heart Valves

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8. GLOBAL CARDIAC VALVE MARKET, BY POSITION

    8.1. Overview

    8.2. Mitral Valve

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3. Aortic Valve

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4. Other Position

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9. GLOBAL CARDIAC VALVE MARKET, BY END USER

    9.1. Overview

    9.2. Hospital & Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3. Specialty Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4. Cardiac Research Institute

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.5. Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10. GLOBAL CARDIAC VALVE MARKET, BY REGION

    10.1. Overview

    10.2. Americas

    10.2.1. North America

    10.2.1.1. US

    10.2.1.2. Canada

    10.2.2. Latin America

    10.3. Europe

    10.3.1. Western Europe

    10.3.1.1. Germany

    10.3.1.2. France

    10.3.1.3. Italy

    10.3.1.4. Spain

    10.3.1.5. UK

    10.3.1.6. Rest of Western Europe

    10.3.2. Eastern Europe

    10.4. Asia-Pacific

    10.4.1. Japan

    10.4.2. China

    10.4.3. India

    10.4.4. Australia

    10.4.5. South Korea

    10.4.6. Rest of Asia-Pacific

    10.5. Middle East & Africa

    10.5.1. Middle East

    10.5.2. Africa

    11. COMPANY LANDSCAPE

    11.1.1. Overview

    11.1.2. Competitive Analysis

    12. COMPANY PROFILES

    12.1. Medtronic

    12.1.1. Company Overview

    12.1.2. Treatment Type Overview

    12.1.3. Financial Overview

    12.1.4. Key Developments

    12.1.5. SWOT Analysis

    12.1.6. Key Strategies

    12.2. Edwards Lifesciences Corporation

    12.2.1. Company Overview

    12.2.2. Treatment Type Overview

    12.2.3. Financial Overview

    12.2.4. Key Developments

    12.2.5. SWOT Analysis

    12.2.6. Key Strategies

    12.3. Boston Scientific Corporation

    12.3.1. Company Overview

    12.3.2. Treatment Type Overview

    12.3.3. Financial Overview

    12.3.4. Key Developments

    12.3.5. SWOT Analysis

    12.3.6. Key Strategies

    12.4. LivaNova PLC

    12.4.1. Company Overview

    12.4.2. Treatment Type Overview

    12.4.3. Financial Overview

    12.4.4. Key Developments

    12.4.5. SWOT Analysis

    12.4.6. Key Strategies

    12.5. Abbott

    12.5.1. Company Overview

    12.5.2. Treatment Type Overview

    12.5.3. Financial Overview

    12.5.4. Key Developments

    12.5.5. SWOT Analysis

    12.5.6. Key Strategies

    12.6. CryoLife, Inc

    12.6.1. Company Overview

    12.6.2. Treatment Type Overview

    12.6.3. Financial Overview

    12.6.4. Key Developments

    12.6.5. SWOT Analysis

    12.6.6. Key Strategies

    12.7. On-X Life Technologies, Inc.

    12.7.1. Company Overview

    12.7.2. Treatment Type Overview

    12.7.3. Financial Overview

    12.7.4. Key Developments

    12.7.5. SWOT Analysis

    12.7.6. Key Strategies

    12.8. Colibri Heart Valve

    12.8.1. Company Overview

    12.8.2. Treatment Type Overview

    12.8.3. Financial Overview

    12.8.4. Key Developments

    12.8.5. SWOT Analysis

    12.8.6. Key Strategies

    12.9. JenaValve Technology, Inc.

    12.9.1. Company Overview

    12.9.2. Treatment Type Overview

    12.9.3. Financial Overview

    12.9.4. Key Developments

    12.9.5. SWOT Analysis

    12.9.6. Key Strategies

    12.10. TTK HealthCare

    12.10.1. Company Overview

    12.10.2. Treatment Type Overview

    12.10.3. Financial Overview

    12.10.4. Key Developments

    12.10.5. SWOT Analysis

    12.10.6. Key Strategies

    12.11. Others

    13. APPENDIX

    13.1. References

    13.2. Related Reports


    LIST OF TABLES

    TABLE 1 GLOBAL CARDIAC VALVE MARKET SYNOPSIS, 2020-2027

    TABLE 2 GLOBAL CARDIAC VALVE MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

    TABLE 3 GLOBAL CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 4 GLOBAL CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 5 GLOBAL CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 6 GLOBAL CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 7 GLOBAL CARDIAC VALVE MARKET, BY REGION, 2020-2027 (USD MILLION)

    TABLE 8 NORTH AMERICA: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 9 NORTH AMERICA: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 10 NORTH AMERICA: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 11 NORTH AMERICA: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 12 US: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 13 US: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 14 US: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 15 US: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 16 CANADA: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 17 CANADA: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 18 CANADA: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 19 CANADA: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 20 LATIN AMERICA: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 21 LATIN AMERICA: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 22 LATIN AMERICA: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 23 LATIN AMERICA: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 24 EUROPE: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 25 EUROPE: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 26 EUROPE: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 27 EUROPE: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 28 WESTERN EUROPE: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 29 WESTERN EUROPE: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 30 WESTERN EUROPE: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 31 WESTERN EUROPE: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 32 EASTERN EUROPE: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 33 EASTERN EUROPE: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 34 EASTERN EUROPE: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 35 EASTERN EUROPE: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 36 ASIA-PACIFIC: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 37 ASIA-PACIFIC: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 38 ASIA-PACIFIC: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 39 ASIA-PACIFIC: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    TABLE 40 MIDDLE EAST & AFRICA: CARDIAC VALVE MARKET, BY TREATMENT, 2020-2027 (USD MILLION)

    TABLE 41 MIDDLE EAST & AFRICA: CARDIAC VALVE MARKET, BY TYPE, 2020-2027 (USD MILLION)

    TABLE 42 MIDDLE EAST & AFRICA: CARDIAC VALVE MARKET, BY POSITION, 2020-2027 (USD MILLION)

    TABLE 43 MIDDLE EAST & AFRICA: CARDIAC VALVE MARKET, BY END USER, 2020-2027 (USD MILLION)

    LIST OF FIGURES

    FIGURE 1 RESEARCH PROCESS

    FIGURE 2 MARKET STRUCTURE OF THE GLOBAL CARDIAC VALVE MARKET

    FIGURE 3 MARKET DYNAMICS OF THE GLOBAL CARDIAC VALVE MARKET

    FIGURE 4 GLOBAL CARDIAC VALVE MARKET SHARE, BY TREATMENT, 2020 (%)

    FIGURE 5 GLOBAL CARDIAC VALVE MARKET SHARE, BY TYPE, 2020 (%)

    FIGURE 6 GLOBAL CARDIAC VALVE MARKET SHARE, BY POSITION, 2020 (%)

    FIGURE 7 GLOBAL CARDIAC VALVE MARKET SHARE, BY END USER, 2020 (%)

    FIGURE 8 GLOBAL CARDIAC VALVE MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 9 AMERICAS: CARDIAC VALVE MARKET SHARE BY REGION, 2020 (%)

    FIGURE 10 NORTH AMERICA: CARDIAC VALVE MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 11 EUROPE: CARDIAC VALVE MARKET SHARE, BY REGION, 2020 (%)

    FIGURE 12 WESTERN EUROPE: CARDIAC VALVE MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 13 ASIA-PACIFIC: CARDIAC VALVE MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 14 MIDDLE EAST & AFRICA: CARDIAC VALVE MARKET SHARE, BY COUNTRY, 2020 (%)

    FIGURE 15 GLOBAL CARDIAC VALVE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

    FIGURE 16 MEDTRONIC: KEY FINANCIALS

    FIGURE 17 MEDTRONIC: SEGMENTAL REVENUE

    FIGURE 18 MEDTRONIC: REGIONAL REVENUE

    FIGURE 19 EDWARDS LIFESCIENCES CORPORATION: KEY FINANCIALS

    FIGURE 20 EDWARDS LIFESCIENCES CORPORATION: SEGMENTAL REVENUE

    FIGURE 21 EDWARDS LIFESCIENCES CORPORATION: REGIONAL REVENUE

    FIGURE 22 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS

    FIGURE 23 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE

    FIGURE 24 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE

    FIGURE 25 LIVANOVA PLC.: KEY FINANCIALS

    FIGURE 26 LIVANOVA PLC.: SEGMENTAL REVENUE

    FIGURE 27 LIVANOVA PLC.: REGIONAL REVENUE

    FIGURE 28 ABBOTT: KEY FINANCIALS

    FIGURE 29 ABBOTT: SEGMENTAL REVENUE

    FIGURE 30 ABBOTT: REGIONAL REVENUE

    FIGURE 31 CRYOLIFE, INC: KEY FINANCIALS

    FIGURE 32 CRYOLIFE, INC.: SEGMENTAL REVENUE

    FIGURE 33 CRYOLIFE, INC.: REGIONAL REVENUE

    FIGURE 34 ON-X LIFE TECHNOLOGIES, INC.: KEY FINANCIALS

    FIGURE 35 ON-X LIFE TECHNOLOGIES, INC.: SEGMENTAL REVENUE

    FIGURE 36 ON-X LIFE TECHNOLOGIES, INC.: REGIONAL REVENUE

    FIGURE 37 COLIBRI HEART VALVE.: KEY FINANCIALS

    FIGURE 38 COLIBRI HEART VALVE.: SEGMENTAL REVENUE

    FIGURE 39 COLIBRI HEART VALVE.: REGIONAL REVENUE

    FIGURE 40 JENAVALVE TECHNOLOGY, INC.: KEY FINANCIALS

    FIGURE 41 JENAVALVE TECHNOLOGY, INC.: SEGMENTAL REVENUE

    FIGURE 42 JENAVALVE TECHNOLOGY, INC.: REGIONAL REVENUE

    FIGURE 43 TTK HEALTHCARE: KEY FINANCIALS

    FIGURE 44 TTK HEALTHCARE: SEGMENTAL REVENUE

    FIGURE 45 TTK HEALTHCARE: REGIONAL REVENUE